Alan Karthikesalingam 246

Dr Alan Karthikesalingam - "Applying machine learning to healthcare"

Alan Karthikesalingam is a senior clinician scientist at DeepMind Health, leading the translation between our Health Research and Streams teams. He is responsible for ensuring the clinical focus of our health research; the prototyping of ML algorithms into devices subject to clinical effectiveness studies; and leads our clinical trials and evaluation across both Research and Streams.

After studying medicine at the University of Cambridge, Alan trained in vascular and endovascular surgery in London, Lille and New York. At St George’ s University of London, he completed his PhD and led a successful research group investigating neural networks for medical imaging, new approaches to registry-based randomised trials, the use of routine data to understand care outcomes and international comparisons of cardiovascular care.

Alongside clinical practice he published over 125 peer-reviewed papers, including award-winning first-author studies in the Lancet and the New England Journal of Medicine. His work supported the centralisation of vascular services in the UK and he remains an honorary Reader (associate professor) at St George’ s, where he was appointed deputy head of the university vascular institute. Prior to joining DeepMind he co-launched an app still in use across the London Ambulance Service in a study of vascular emergency triage. 

In this talk, Dr Alan Karthikesalingam (Research Lead) will explore the challenges facing modern medicine, and evaluate how digital tools and advanced technologies - such as artificial intelligence - can help address them. Using his experience as a vascular surgeon, as well as the recent work that DeepMind Health are doing, Alan will demonstrate how new advances can help clinicians deliver better, faster care to patients. 

AOMRC 19 07 17 0572r Carrie photoProfessor Caroline MacEwen,
Chair, Academy of Medical Royal Colleges

Professor Caroline (Carrie) MacEwen is Chair of the Academy of Medical Royal Colleges (2017–2020). She is immediate past President of the Royal College of Ophthalmologists (2014 – 2017) and a Consultant Ophthalmologist at Ninewells Hospital, Dundee. She is also an Associate post-graduate Dean in the East of Scotland for less than full time post-graduate medical training.

Carrie has always worked as a full-time clinician and received an Honorary Chair as Head of the Department of Ophthalmology at the University of Dundee, publishing more than 150 papers, writing and contributing to several textbooks and leading ophthalmology teaching.

She is ophthalmology clinical co-lead for the Getting It Right First Time (GIRFT) project, was a member of the Right Care Clinical Improvement Group and chaired the Elective Care Transformation Ophthalmology Working Group. She was a member of the Sir Norman Williams review into Gross Negligence Manslaughter for the Secretary of State.

She is Ophthalmology Specialty Adviser to the Scottish Government and leads the National Ophthalmology Workstream in Scotland and is a member of the National Access Collaborative. 

Professor MacEwen chaired the Scottish update of Certification of Vision Impairment and was a member of the UKCVI development board, the UK Vision Strategy Leadership Group and Transition Programme Board.

Carrie has worked nationally with all eye health care professionals to share and develop new ways of delivering ophthalmic care and has delivered a framework to support this.  She has been made an honorary fellow of the College of Optometrists and the British and Irish Orthoptic Society, the Faculty of Sport and Exercise Medicine and the Royal College of Physicians, Edinburgh.

Carrie is an Associate Editor of the Scientific Journal “Eye”. She has been elected Master of the Oxford Ophthalmological Congress (2017-2018), the oldest UK wide national ophthalmic conference.

This year, Jeremy Farrar is one of our key note speakers.

jeremy farrarJeremy Farrar is director of the Wellcome Trust, an independent British charitable foundation that persues a better health worldwide. Before joining Wellcome in October 2013, Jeremy was Director of the Oxford University Clinical Research Unit in Vietnam for 18 years. His research interests were infectious diseases, tropical health and emerging infections. He has published over 500 peer-reviewed scientific papers, mentored many dozens of students and fellows, and served as Chair on several advisory boards for governments and global organisations, including the World Health Organization. He was named 12th in Fortune's list of the World's 50 Greatest Leaders in 2015.

Jeremy was appointed OBE in 2005 for services to tropical medicine, was awarded the Memorial Medal and the Ho Chi Minh City Medal by the Government of Vietnam, and has been honoured by the Royal College of Physicians in the UK and the American Society for Tropical Medicine and Hygiene. He is a Fellow of both the Academy of Medical Sciences and the Royal Society.

Thursday June 6


image001Professor Sir Peng Tee KhawPhD FRCS FRCP FRCOphth FRCPath FRSB FCOptom (Hon) DSc FARVO FMedSci Professor of Glaucoma and Ocular Healing and Consultant Ophthalmic Surgeon.Director of the NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Research and Development, Moorfields Eye Hospital and; Eyes and Vision Programme, UCL Partners Academic Health Science Centre. Sir Peng’s research interests are in developing new therapies, particularly for preventing scarring and regeneration, with a special interest in paediatric and young adult glaucoma. He has developed surgical techniques including the Moorfields Safer Surgery System, which have markedly improved the safety and outcomes of antimetabolite-assisted trabeculectomy in many parts of the world, especially reducing bleb related endophthalmitis and blebitis. He has developed anti-scarring regimens, which have led to international clinical trials. Currently, he is developing new anti-scarring drugs and delivery system, as well as devices, and has proposed the 10-10-10 challenge for glaucoma around the world: an intraocular pressure of 10 mmHg for 10 years done in 10 minutes. He has also published the ‘energy’ theory of glaucomatous axonopathy, helping move towards stem cell regenerative therapies for the optic nerve. His publications include over 450 papers, chapters and books, and has helped raise over £120 million for clinical and research facilities, including the world’s largest children’s eye hospital. He was the first British President of ARVO and with his group has won some 25 awards, which include the first international ARVO/Pfizer Ophthalmic Translational Research Award; Alcon Research Institute Award; Sir Stewart Duke Elder Lecture & Medal Royal College of Ophthalmologists; 12th Lang Lecture Medal Royal Society of Medicine; the 23rd Dame Ida Mann Lecture Oxford University; and Hunterian Professorship at the Royal College of Surgeons of England. Sir Peng was knighted in 2013 for services to ophthalmology by Her Majesty Queen Elizabeth II.

Georgie Bullen - Director of Team Insight & Content Manager, RNIB

georgieGeorgie has been severely visually impaired since she was five years old. She has gone on to represent Great Britain in the Paralympic sport of Goalball for over 10 years, including competing at the 2012 Paralympics. Alongside her sporting career, Georgie has launched a successful business, which delivers corporate team building and visual impairment awareness training events. In the last few months, Georgie has taken on a new challenge as RNIB’s Content Manager and aims to help spread the organisation’s new message of getting people to ‘See Differently’ about sight loss.

Marc Powell -  Innovation Strategist & Accessibility Evangelist, RNIB

IMG 0689Marc is a passionate advocate within the world of accessibility, having represented the RNIB since retiring from his professional sporting career as a Paralympic judo athlete. Marc has worked closely with many international organisations to improve accessibility and address some of the barriers faced by visually impaired people.  Marc himself has a genetic eye condition called Cone Rod Dystrophy, which has affected him since birth. He has been featured in many social media campaigns which aim to educate the public on the ‘spectrum of sight loss’ and takes every opportunity to raise awareness of visual impairment.

Professor Nora Ann Colton

Nora Colton picProfessor Nora Ann Colton is Director of Education at UCL Institute of Ophthalmology and Moorfields Eye Hospital where she oversees the development of a joint education strategy aimed at bringing these two organisations together to offer world leading education in vision and eye health. Nora was previously the Deputy Vice Chancellor (Academic) at the University of East London where she oversaw all academic affairs. She is a Principal Fellow of the Higher Education Academy. She serves as a nonexecutive and governor on a number of boards including Chair of Vision Aid Overseas. Before coming to the UK, she was a Professor and Chair of the Economics Department at Drew University in New Jersey, USA. She received her D.Phil. from St. Antony's College, Oxford University, in economics with specialisations in health economics and the Middle East. She is fluent in Arabic. She has been a visiting Professor at American University in Beirut and the University of Electronic Science and Technology in Chengdu, China.

Tim Johnson - Partner, More Partnership - Formerly CEO, Great Ormond Street Hospital Charity

Tim JohnsonThe World Association of Eye Hospitals is delighted to announce Tim Johnson as the keynote speaker for the special philanthropy and eye health workshop which will take place on Wednesday 5 June 2019 as part of WAEH 2019.  Tim Johnson is a Partner at More Partnership, an international fundraising consulting firm.  Tim was previously Director of Development and then Chief Executive of Great Ormond Street Hospital Charity (until March 2019).  Under Tim’s leadership Great Ormond Street Hospital Charity has raised over £1bn since 2002 towards treating more patients, advancing pioneering research to improve patient outcomes and helping to enhance the experience for patients and their families.  

Robert Dufton, CEO of Moorfields Eye Charity and Chair of WAEH philanthropy and eye health workshop said:  “We are delighted to welcome Tim Johnson as our keynote speaker.  Tim has significantly increased the amount of funds raised to support one of the world’s leading centres in children’s healthcare (and which is a partner of Moorfields Eye Hospital with whom it has five jointly appointed paediatric ophthalmologist consultants) but he has also introduced high standards of fundraising and good governance.  He is one of the leading advisers on fundraising across the health sector and more broadly.”